We develop AI-powered software solutions to transform genetic disease diagnosis, making it faster, more accurate, and affordable. Our tools support clinicians by identifying genetic variants and predicting outcomes, reducing diagnostic uncertainty for patients with genetic conditions.
To empower clinicians and researchers with innovative AI-driven tools for rapid, accurate, and affordable genetic disease diagnosis, transforming the diagnostic journey for patients and improving access to timely, personalized care.
To become a global leader in genetic disease diagnostics, bridging the gap between advanced technology and patient care. We envision a world where no patient with a genetic condition experiences delays or uncertainty in diagnosis, fostering a future of equitable, precision-driven healthcare for all.
CEO
Genomics researcher with extensive experience in AI applications for healthcare. Passionate about democratizing genetic diagnosis across India.
Director of Bioinformatics
AI specialist with background in bioinformatics. Leading our genomic data analysis pipeline and machine learning implementations for variant classification.
Bioinformatics Engineer
Specialized in genomic data analysis and interpretation. Focused on improving variant classification accuracy for Indian genetic profiles.
Data Science Intern
Working on machine learning models for genetic variant classification and contributing to the development of AIVA's AI capabilities.
CEO at IKP Knowledge Park
Providing strategic guidance and industry insights to help Mamidi Health navigate the healthcare technology landscape.
Sr. General Manager & Regional Head CIS (BG Markets) at Hetero
Supporting the team with expertise in go-to-market strategy and business development for the Indian healthcare market.
Our journey of innovation in genomic diagnostics
Developed automated classification system for variant annotations, enhancing diagnostic accuracy and eliminating the need for manual review of each variant
Created advanced technology for identifying biological associations between variants, genes, phenotypes, and potential treatments, providing deeper insights for clinicians
Reduced genetic analysis time from weeks to hours, revolutionizing diagnostic turnaround times and enabling faster clinical decision-making
Putting patient needs at the center of everything we do
Continuously advancing our technology for better outcomes
Ensuring precise and reliable diagnostic results
Making advanced diagnostics available to all
